Longevity defined as top 10% survivors and beyond is transmitted as a 
quantitative genetic trait

van den Berg, N.; Rodríguez-Girondo, M.; van Dijk, I. K.; Mourits, R. J.; Mandemakers, K.; Janssens, Aapo; Beekman, M.; Smith, K. R.; Slagboom, P. E.

doi:10.1038/s41467-018-07925-0

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

Longevity defined as top 10% survivors and beyond is transmitted as a quantitative genetic trait

MPS-Authors

/persons/resource/persons278141

Slagboom, P. E.
Slagboom – Molecular Epidemiology, External and Associated Groups, Max Planck Institute for Biology of Ageing, Max Planck Society;

External Resource

https://pubmed.ncbi.nlm.nih.gov/30617297/
(Any fulltext)

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

van den Berg, N., Rodríguez-Girondo, M., van Dijk, I. K., Mourits, R. J., Mandemakers, K., Janssens, A., et al. (2019). Longevity defined as top 10% survivors and beyond is transmitted as a quantitative genetic trait. Nat Commun, 10(1), 35. doi:10.1038/s41467-018-07925-0.

Cite as: https://hdl.handle.net/21.11116/0000-000B-3F56-F

Abstract

Survival to extreme ages clusters within families. However, identifying genetic loci conferring longevity and low morbidity in such longevous families is challenging. There is debate concerning the survival percentile that best isolates the genetic component in longevity. Here, we use three-generational mortality data from two large datasets, UPDB (US) and LINKS (Netherlands). We study 20,360 unselected families containing index persons, their parents, siblings, spouses, and children, comprising 314,819 individuals. Our analyses provide strong evidence that longevity is transmitted as a quantitative genetic trait among survivors up to the top 10% of their birth cohort. We subsequently show a survival advantage, mounting to 31%, for individuals with top 10% surviving first and second-degree relatives in both databases and across generations, even in the presence of non-longevous parents. To guide future genetic studies, we suggest to base case selection on top 10% survivors of their birth cohort with equally long-lived family members.